Clinical trial data can often exhibit a significant imbalance. Certain data modalities, such as imaging or genomic data, may not be available for a given clinical trial, posing a challenge in integrating diverse data types in a meaningful manner. This challenge may result in the development of models that are biased towards specific modalities, affecting their accuracy and generalizability.